Off-Label Dosing of Direct Oral Anticoagulants: Prescribing Error or Opportunity in Treating Patients with Atrial Fibrillation?
Thrombosis and Haemostasis · 01.03.2025 · 125 (03) · 286-289
DOI: 10.1055/a-2441-8902 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.03.2025. Verfasst von Daniela Poli. Beteiligte Einrichtung: Department of Critical Care Medicine, Thrombosis Centre, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Critical Care Medicine, Thrombosis Centre, Azienda Ospedaliera Universitaria Careggi, Firenze, Italy.
Zitieren
APA
Poli, D. (2025). Off-Label Dosing of Direct Oral Anticoagulants: Prescribing Error or Opportunity in Treating Patients with Atrial Fibrillation?. Thrombosis and Haemostasis, 125(03), 286-289. https://doi.org/10.1055/a-2441-8902
Vancouver
Poli D. Off-Label Dosing of Direct Oral Anticoagulants: Prescribing Error or Opportunity in Treating Patients with Atrial Fibrillation?. Thrombosis and Haemostasis. 2025;125(03):286-289. doi:10.1055/a-2441-8902
BibTeX
@article{Poli2025,
author = {Poli, Daniela},
title = {Off-Label Dosing of Direct Oral Anticoagulants: Prescribing Error or Opportunity in Treating Patients with Atrial Fibrillation?},
journal = {Thrombosis and Haemostasis},
year = {2025},
volume = {125},
number = {03},
pages = {286--289},
doi = {10.1055/a-2441-8902}
}
EUVIMED